Clinical trials
for patients
Learn about available clinical trials
-
May 9, 2025PamplonaIn recruitment
C4951013 Phase III, randomized, double-blind, placebo-controlled, efficacy and safety clinical trial, followed by an open-label period, to investigate rimegepant in the prevention of migraine in adolescents aged 12 to less than 18 years.
The purpose of this study is to learn about the effects of the study drug (rimegepant) and to assess the safety (the impact of the study drug on your child's body) when used as a preventive treatment for chronic migraine. -
May 8, 2025Pamplona/MadridIn recruitment
ANT-008 Trial comparing the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with VTE associated with gastrointestinal (GI) or genitourinary cancer.
The aim of the study is to determine the ability of abelacimab to reduce blood clotting with possibly fewer bleeding episodes. -
May 7, 2025Pamplona/MadridIn recruitmentEarly phase
LATE-R-GEL-23 Multicenter, open-label, single-arm, multicenter phase II clinical trial to evaluate the efficacy of axicabtagene ciloleucel in patients with late relapsed diffuse large B-cell lymphoma
The aim of the study is to evaluate the efficacy of the study treatment, axicabtagene ciloleucel, when administered to patients with aggressive BGCL as a second line (meaning that the patient must have received another treatment before). -
May 7, 2025Pamplona/MadridIn recruitment
0209-01 Clinical trial of CPI-0209 in patients with advanced solid tumors and lymphomas
The aim of conducting this trial is to find a dose of CPI-0209 whose side effects are acceptable and which may be useful in the treatment of patients with advanced tumors. Another objective of the trial is to monitor blood levels of CPI-0209. -
May 7, 2025PamplonaIn recruitment
D6972C00002 Phase III trial to evaluate the efficacy, safety and tolerability of Baxdrostat combined with Dapagliflozin, compared to Dapagliflozin monotherapy, on renal outcomes and cardiovascular mortality in patients with CKD
The aim of this study is to learn more about the benefits and safety of the treatment of an investigational drug called baxdrostat in combination with dapagliflozin for the treatment of patients with CKD and high blood pressure. We also want to better understand CKD and its accompanying health problems. -
April 30, 2025MadridIn recruitment
-
April 28, 2025Pamplona/MadridIn recruitmentEarly phase
GO44537 Clinical trial to evaluate the safety, pharmacokinetics and activity of RO7656594 in patients with advanced or metastatic prostate cancer.
The objective of this study is to evaluate RO7656594 at different doses to determine if it is safe and how it is processed by your body. The study consists of two parts: a dose-finding stage and a scale-up stage. -
April 28, 2025MadridIn recruitment
MK-2870-022 Phase 3 clinical trial to evaluate the efficacy and safety of maintenance therapy with sacituzumab tirumotecan versus standard therapy in platinum-sensitive recurrent ovarian cancer.
The main objective is to evaluate the safety and tolerability of tirumotecan sacituzumab in maintenance treatment with bevacizumab. -
April 14, 2025PamplonaIn recruitment
OROLEAK Clinical trial for the evaluation of oropharyngeal leak in second- and third-generation laryngeal masks: impact on clinical practice
Our main objective is to measure the pressures occurring in the esophagus and determine whether they are a risk factor for vomiting, by comparing two commercially available laryngeal masks. -
April 9, 2025PamplonaIn recruitment
REGISTRO VASOPRES Ensayo clínico de vasopresina para el shock
The main objective is to characterize the routine clinical practice of vasopressin use in the context of shock in a multicenter observational study.